MR Contrast Agents: What Is Their Value?
Thursday, Dec. 2, 3:00 – 4:00 PM
This session is examining the cases for and against Gd-EOB-DTPA and Gadofosveset and offering insights into Gadobutrol. Speakers also are presenting on-label applications, off-label possibilities and opportunities for using new agents in clinical practice.
- Elmar Merkle, MD, department of radiology, Duke University in Durham, N.C.; and
- Neil Mitchell Rofsky, MD, chief, MRI, Beth Israel Deaconess Medical Center in Boston.